Overlapping network meta-analyses on psoriasis systemic treatments, an overview: quantity does not make quality
Guelimi R, Afach S, Régnaux JP, Bettuzzi T, Chaby G, Sbidian E, Naudet F, Le Cleach L.
Br J Dermatol. 2022 Jul;187(1):29-41.
doi: 10.1111/bjd.20908. Epub 2022 Apr 12. PMID: 34854074 Review.
Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs
Grolleau C, Le Cleach L, Shourick J, Sbidian E, Afach S.
Br J Dermatol. 2023 Jan 26:ljac142.
doi: 10.1093/bjd/ljac142. Online ahead of print. PMID: 36702800 No abstract available.
Prevalence of medication administration errors in hospitalized adults: A systematic review and meta-analysis up to 2017 to explore sources of heterogeneity
Azar C, Raffoul P, Rizk R, Boutros C, Saleh N, Maison P.
Fundam Clin Pharmacol. 2023 Jan 23.
doi: 10.1111/fcp.12873. Online ahead of print. PMID: 36691676 Review.
Placebo response in moderate-to-severe psoriasis: prevalence meta-analysis of randomised controlled trials
Afach S, Le Cleach L, Sbidian E.
J Invest Dermatol. 2022 Dec 20:S0022-202X(22)02892-5.
doi: 10.1016/j.jid.2022.10.024. Online ahead of print. PMID: 36563778 No abstract available.
Overlapping network meta-analyses on psoriasis systemic treatments, an overview: quantity does not make quality
Guelimi R, Afach S, Régnaux JP, Bettuzzi T, Chaby G, Sbidian E, Naudet F, Le Cleach L.
Br J Dermatol. 2022 Jul;187(1):29-41.
doi: 10.1111/bjd.20908. Epub 2022 Apr 12. PMID: 34854074 Review.
Network meta-analysis: methodological points for readers, authors and reviewers
Guelimi R, Metelli S, Sbidian E, van Zuuren EJ, Flohr C, Leonardi-Bee J, Le Cleach L.
Br J Dermatol. 2022 Jun;186(6):917-918.
doi: 10.1111/bjd.21013. PMID: 35657177 No abstract available.
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Sbidian E, Chaimani A, Garcia-Doval I, Doney L, Dressler C, Hua C, Hughes C, Naldi L, Afach S, Le Cleach L.
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535.
doi: 10.1002/14651858.CD011535.pub5. PMID: 35603936 Review.
Meta-analysis results do not reflect the real safety of biologics in psoriasis
Afach S, Chaimani A, Evrenoglou T, Penso L, Brouste E, Sbidian E, Le Cleach L.
Br J Dermatol. 2021 Mar;184(3):415-424.
doi: 10.1111/bjd.19244. Epub 2020 Jul 16. PMID: 32446286 Review.
Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments
Afach S, Evrenoglou T, Oubaya N, Le Cleach L, Sbidian E.
J Clin Epidemiol. 2021 Jan 20;133:72-79.
doi: 10.1016/j.jclinepi.2021.01.013. Online ahead of print. PMID: 33482295.
A Markov chain approach for ranking treatments in network meta-analysis
Chaimani A, Porcher R, Sbidian É, Mavridis D.
Stat Med. 2021 Jan 30;40(2):451-464.
doi: 10.1002/sim.8784. Epub 2020 Oct 26. PMID: 33105517 Free PMC article.
Research Techniques Made Simple: Randomized Controlled Trials for Topical Drugs in Dermatology: When and How Should We Use a Within-Person Design?
Leducq S, Caille A, Le Cleach L, Samimi M, Tavernier E, Maruani A, Giraudeau B.
J Invest Dermatol. 2020 May;140(5):931-938.e1.
doi: 10.1016/j.jid.2020.03.945. PMID: 32331567 Review.
Quality and Reporting Completeness of Systematic Reviews and Meta-Analyses in Dermatology
Smires S, Afach S, Mazaud C, Phan C, Garcia Doval I, Boyle R, Dellavalle R, Williams HC, Grindlay D, Sbidian E, Le Cleach L.
J Invest Dermatol. 2021 Jan;141(1):64-71.
doi: 10.1016/j.jid.2020.05.109. Epub 2020 Jun 27. PMID: 32603750.
Twenty percent of secondary publications of randomized controlled trials of drugs did not provide new results relative to the primary publication
Lai C, Sbidian E, Giraudeau B, Le Cleach L.
J Clin Epidemiol. 2020 Jan;117:20-28.
doi: 10.1016/j.jclinepi.2019.09.012. Epub 2019 Sep 20. PMID: 31546006.